Celebrex (celecoxib) is generally safe for most people when used as directed, and large-scale clinical evidence suggests it carries no greater cardiovascular risk than common over-the-counter painkillers like ibuprofen or naproxen. That said, it does come with real risks, particularly for your stomach, heart, and kidneys, and those risks change depending on your health history, how long you take it, and what other medications you use.
How Celebrex Differs From Other NSAIDs
Celebrex belongs to the same broad family as ibuprofen and naproxen, but it works differently at the molecular level. Your body produces two types of an enzyme called COX. COX-1 maintains the protective lining of your stomach and intestines and plays a role in blood clotting. COX-2 ramps up at sites of inflammation and drives pain and swelling. Ibuprofen and naproxen block both enzymes. Celebrex selectively targets COX-2 while largely leaving COX-1 alone.
This selectivity is the reason Celebrex exists. By sparing COX-1, it causes less damage to the stomach lining, which makes it a better option for people who need daily pain relief but are prone to gastrointestinal problems.
What It’s Prescribed For
Celebrex is FDA-approved for osteoarthritis (typically 200 mg per day), rheumatoid arthritis (200 to 400 mg per day), ankylosing spondylitis, acute pain, and menstrual pain. It’s also approved for juvenile rheumatoid arthritis in children aged 2 and older, with doses based on body weight. For short-term acute pain, the starting dose is higher (400 mg on the first day), then drops to 200 mg twice daily as needed.
Cardiovascular Risk: What the Evidence Shows
The biggest safety concern around Celebrex has been heart risk. An earlier COX-2 inhibitor, rofecoxib (Vioxx), was pulled from the market in 2004 after it was linked to heart attacks, and that cast a shadow over the entire drug class. Celebrex carries an FDA boxed warning stating that all NSAIDs increase the risk of serious cardiovascular events, including heart attack and stroke, and that this risk may grow with longer use.
However, the strongest evidence we have suggests Celebrex is no worse than the alternatives. The PRECISION trial, a decade-long study of more than 24,000 arthritis patients who already had heart disease or elevated cardiovascular risk, directly compared Celebrex to ibuprofen and naproxen at prescription-strength doses. Heart attack, stroke, or death occurred in 2.3 percent of patients on Celebrex, compared to 2.5 percent on naproxen and 2.7 percent on ibuprofen. The study concluded with strong statistical confidence that Celebrex is not more dangerous for the heart than the other two drugs.
A 2021 meta-analysis pooling data from 21 clinical trials reinforced this. Compared to traditional NSAIDs, Celebrex showed a slightly lower rate of cardiovascular death and a modestly lower rate of death from all causes. The authors concluded that Celebrex is “relatively safe in rheumatoid arthritis and osteoarthritis patients, independent of dose or duration,” though they noted that certainty drops for patients already on aspirin or with established cardiovascular disease.
Stomach and Digestive Safety
This is where Celebrex has a genuine advantage. Because it doesn’t suppress COX-1, it’s significantly less likely to cause stomach ulcers and gastrointestinal bleeding than traditional NSAIDs. In a randomized trial of patients who had already experienced upper gastrointestinal bleeding (a high-risk group), those given Celebrex plus a stomach-protecting acid blocker had a 5.6 percent rate of recurrent bleeding over 18 months, compared to 12.3 percent for those on naproxen with the same acid blocker. That’s roughly half the risk.
Still, the risk isn’t zero. The FDA label is clear that Celebrex can cause gastrointestinal bleeding, ulceration, and even perforation, and these events can happen at any point during treatment without warning symptoms. Older adults and anyone with a history of ulcers or GI bleeding face the highest risk.
Effects on Your Kidneys
All NSAIDs affect kidney function to some degree, and Celebrex is no exception. In the first day or two of use, it commonly causes mild fluid retention and a slight increase in blood pressure as your kidneys temporarily hold on to extra sodium and water. In healthy people, this resolves quickly and the body returns to baseline.
The concern is greater if your kidneys are already under stress. In patients with mildly reduced kidney function, Celebrex performed better than ibuprofen or diclofenac in clinical comparisons: about 3.7 percent experienced meaningful drops in kidney function, compared to 7.3 percent for each of the other two drugs. If you have high blood pressure, the fluid retention can destabilize your blood pressure control, which is something worth monitoring with your prescriber.
Drug Interactions to Know About
Taking Celebrex alongside low-dose aspirin is common for people managing both pain and heart risk, but the combination increases your chance of gastrointestinal ulcers and bleeding. Both drugs are technically NSAIDs, and stacking two NSAIDs compounds digestive risk. If you need both, your prescriber may add a stomach-protecting medication or monitor you more closely.
Other medications and factors that raise bleeding risk when combined with Celebrex include blood thinners, oral corticosteroids, and selective serotonin reuptake inhibitors (SSRIs, a class of antidepressants). Alcohol use and smoking also increase the likelihood of GI complications.
The Sulfa Allergy Question
Celebrex contains a sulfonamide group in its chemical structure, which leads many people with “sulfa allergies” to worry about taking it. Current evidence shows this concern is largely unfounded. The sulfonamide antibiotics that cause allergic reactions (like sulfamethoxazole) have a specific chemical feature, an arylamine group, that Celebrex and other non-antibiotic sulfonamides lack. Without that structure, Celebrex doesn’t trigger the same immune response.
A 2025 review in the Cleveland Clinic Journal of Medicine confirmed that patients with a history of allergic or anaphylactic reactions to sulfonamide antibiotics can receive Celebrex “without elevated risk of an IgE-mediated reaction compared with the general population.” The same applies to severe skin reactions like Stevens-Johnson syndrome: because Celebrex doesn’t produce the same metabolites as sulfonamide antibiotics, it doesn’t cross-react.
Who Should Be Most Cautious
Celebrex is contraindicated if you’re about to have or recently had coronary artery bypass graft surgery. Beyond that absolute restriction, several groups face elevated risk and need careful consideration before starting it:
- People with existing heart disease: The PRECISION trial included these patients and found Celebrex no worse than alternatives, but the overall risk of cardiovascular events on any NSAID is still real. Using the lowest effective dose for the shortest time remains the standard approach.
- Older adults: Both GI and kidney risks rise with age, and older adults are more likely to be on other medications that interact with Celebrex.
- People with a history of ulcers or GI bleeding: Celebrex is safer than traditional NSAIDs for this group, but it still carries risk, particularly without a stomach-protecting medication alongside it.
- People with kidney disease or uncontrolled high blood pressure: The fluid retention effects of Celebrex can worsen both conditions, though data suggests it’s gentler on the kidneys than ibuprofen or diclofenac.
For people without these risk factors who need regular pain relief for arthritis or other chronic inflammatory conditions, Celebrex is one of the safer NSAID options available, particularly if stomach protection is a priority.